TotalMarketCap

Nektar Therapeutics

NKTRNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.244 B

$36.43 -5.34%

Close of 6 Nov 2026

As of 6 Nov 2026, Nektar Therapeutics (NKTR) has a market capitalization of $1.24B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$55.2M

#2681 by revenue

Earnings

-$164.0M

Loss-making

Shares outstanding

34,142,994

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #132GH ResearchGHRS$1.26B
  2. #133UroGen PharmaURGN$1.26B
  3. #134Nektar TherapeuticsNKTR$1.24B
  4. #135OmerosOMER$1.24B
  5. #136Lb PharmaceuticalsLBRX$1.23B

What if Nektar Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$827,018.09

Per share 22,705× higher

Bitcoin $1.53T

$44,748.51

Per share 1,229× higher

Apple $5.02T

$146,905.18

Per share 4,033× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Nektar Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.